Medicare Enrolled
Dr. Jesse Romeu-Velez, MD
Pulmonary Disease · Winter Haven, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Romeu-Velez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Romeu-Velez?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Romeu-Velez
Dr. Jesse Romeu-Velez is a pulmonary disease specialist in Winter Haven, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Romeu-Velez performed 2,912 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Romeu-Velez received a total of $15,197 from 50 pharmaceutical and/or device companies across 664 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Romeu-Velez is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 19% volume in FL
$15,197 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 114215 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗2,912
Medicare services
Top 19% in FL for pulmonary disease
Not available
Unique patients (not deduplicated)
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
558 | $64 | $150 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
503 | $38 | $164 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
493 | $38 | $157 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
406 | $88 | $218 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
333 | $26 | $65 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
196 | $18 | $403 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
116 | $77 | $217 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
49 | $102 | $283 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
47 | $98 | $465 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
41 | $25 | $102 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
41 | $63 | $148 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
38 | $124 | $333 |
| Low dose CT scan of chest for lung cancer screening A specialized CT scan of the chest using a lower radiation dose to screen for lung cancer. |
31 | $137 | $406 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
29 | $94 | $213 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
18 | $24 | $96 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
13 | $8 | $9 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$15,197
Total received (2018-2024)
Avg $2,171/year across 7 years
Top 15% in FL for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
664
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,214
2023
$2,238
2022
$1,664
2021
$2,048
2020
$1,837
2019
$2,787
2018
$2,409
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$429
GlaxoSmithKline, LLC.
$336
Bayer Healthcare Pharmaceuticals Inc.
$241
Pulmonx Corporation
$229
Takeda Pharmaceuticals U.S.A., Inc.
$187
Actelion Pharmaceuticals US, Inc.
$184
GENZYME CORPORATION
$134
Regeneron Healthcare Solutions, Inc.
$129
Merck Sharp & Dohme LLC
$116
Boehringer Ingelheim Pharmaceuticals, Inc.
$89
Mylan Specialty L.P.
$46
United Therapeutics Corporation
$34
3B Medical, Inc.
$32
Amgen Inc.
$28
Top 3 companies account for 45.4% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$3,387
Actelion Pharmaceuticals US, Inc.
$2,126
AstraZeneca Pharmaceuticals LP
$2,109
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,341
Merck Sharp & Dohme LLC
$557
Takeda Pharmaceuticals U.S.A., Inc.
$533
Grifols USA, LLC
$389
Mylan Specialty L.P.
$382
Bayer Healthcare Pharmaceuticals Inc.
$372
Genentech USA, Inc.
$368
Regeneron Healthcare Solutions, Inc.
$352
PFIZER INC.
$283
Pulmonx Corporation
$273
GENZYME CORPORATION
$265
Bayer HealthCare Pharmaceuticals Inc.
$236
Merck Sharp & Dohme Corporation
$230
United Therapeutics Corporation
$188
Amgen Inc.
$170
PORTOLA PHARMACEUTICALS, INC.
$111
Allergan Inc.
$107
Novartis Pharmaceuticals Corporation
$97
Insmed, Inc.
$97
Alnylam Pharmaceuticals Inc.
$96
Novo Nordisk Inc
$93
Astellas Pharma US Inc
$93
SANOFI-AVENTIS U.S. LLC
$85
Teva Pharmaceuticals USA, Inc.
$76
CSL Behring
$75
Advanced Respiratory, Inc
$64
Circassia Pharmaceuticals Inc
$61
Mallinckrodt Hospital Products Inc.
$61
Axsome Therapeutics, Inc.
$53
Lilly USA, LLC
$43
Electromed, Inc.
$42
Paratek Pharmaceuticals, Inc.
$41
Baxter Healthcare
$41
JAZZ PHARMACEUTICALS INC.
$38
Sunovion Pharmaceuticals Inc.
$37
3B Medical, Inc.
$32
Horizon Therapeutics plc
$29
Shire North American Group Inc
$21
Jazz Pharmaceuticals Inc.
$21
Philips Electronics North America Corporation
$21
Eisai Inc.
$18
Phadia US Inc.
$17
Inspire Medical Systems, Inc.
$17
Gilead Sciences, Inc.
$17
Veran Medical Technologies, Inc.
$11
Fisher & Paykel Healthcare Inc
$11
Inogen, Inc.
$9
Top 3 companies account for 50.2% of all-time payments
Associated products mentioned in payments ›
(6299) DreamWear · ACTHAR · AIRSUPRA · ANDEXXA · ANORO · ANORO ELLIPTA · AREXVY · ASMANEX · Adempas · AirDuo Digihaler · Arikayce · BELSOMRA · BEVESPI AEROSPHERE · BEXSERO · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · CAPVAXIVE · CHANTIX · CHARTIS CATHETER · DALIRESP · DUPIXENT · Dayvigo · Dymista · ELIQUIS · Esbriet · FARXIGA · FASENRA · FORTEO · GARDASIL · GLASSIA · Hillrom - Vest System Model 105 Home Care · INSPIRE · ImmunoCAP · InogenOne · JANUVIA · LONHALA MAGNAIR · LUNA · NONE · NUCALA · NUZYRA · OFEV · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · Obstructive Sleep Apnea Device or Hospital Respiratory Equipment · Ozempic · Prolastin-C · Prolastin-C Liquid · RAYOS · Repatha · SHINGRIX · SMARTVEST · SOLIQUA · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Spin · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · Utibron · VERQUVO · VRAYLAR · WINREVAIR · XOLAIR · Xolair · YUPELRI · Yupelri · Zemaira
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
17
County median income
$63,644
Nearest hospital to ZIP centroid (approximate)
WINTER HAVEN HOSPITAL
6.0 mi
6.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Romeu-Velez is a clinical cardiology specialist, with above-average Medicare volume (top 19% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Romeu-Velez experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Romeu-Velez performed 558 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Romeu-Velez receive payments from pharmaceutical companies?
Yes. Dr. Romeu-Velez received a total of $15,197 from 50 companies across 664 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Romeu-Velez's costs compare to other pulmonary diseases in Winter Haven?
Dr. Romeu-Velez's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Romeu-Velez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Winter Haven
Browse pulmonary diseases in Winter Haven ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in FL
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in FL
Which FL pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Actelion Pharmaceuticals US, Inc. Payments to Doctors
See all physicians who received payments from Actelion Pharmaceuticals US, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology